FDA Inspection
Catalent Pharma Solutions LimitedCatalent Pharma Solutions Limited – FDA Inspection, Aug 23, 2018
Record Details
This FDA Inspection record concerns Catalent Pharma Solutions Limited, with an inspection on August 23, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 42adcb22-d2e8-4784-abfc-f8f095cc2170
Inspection Facts
- Inspection number
- 1065786
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Catalent Pharma Solutions Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| October 10, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 20, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
Other documents for Catalent Pharma Solutions Limited
- FDA Inspection 1267053 - 2024-10-10
- FDA Inspection 1261182 - 2023-06-15
- FDA Inspection 1141164 - 2020-02-20
- FDA Inspection 1064287 - 2018-07-26
- FDA Inspection 1048918 - 2018-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.